Figure 3
From: Complete response for advanced liver cancer during sorafenib therapy: Case Report
Six months follow up with MRI before and after injection of Primovist: 3a, T1-weighted; 3b, T2-weighted; 3c, arterial phase; 3d, portal venous phase; e, hepatobiliary phase. At six months of treatment, the liver injury is no longer recognizable at MRI examination and the left portal branch is fully recanalized, as with almost complete response to treatment.